Therefore, we evaluated prognostic significance of different types of KIT mutations and RUNX1-RUNX1T1 quantification in high-risk AML patients with RUNX1-RUNX1T1 who underwent Allo-HSCT or Auto-HSCT to clarify the clinical relevance of each transplant strategy in each risk group. Here, KIT is linked to acute myeloid leukemia.